Citations

Mayo Clinic

Showing 10 of 108585 citations.

Immunogenicity of hepatic differentiated human umbilical cord mesenchymal stem cells promoted by porcine decellularized liver scaffolds
Li, Yi , Wu, Qiong , Wang, Yujia , Li, Li , Shi, Yujun , Bu, Hong , Bao, Ji , Bao, Ji , Chen, Fei

Xenotransplantation | January 19, 2017 | Volume: 24 | Issue: 1 | Pages: No page available

10.1111/xen.12287 | PMID 28102609 Get It

AbstractCell‐based approaches, including hepatocyte transplantation and tissue‐engineered livers, offer promising alternatives and are expected to help support patients with liver diseases until liver transplantation or recovery via regeneration of the damaged liver. However, the success of cell therapies remains dependent on how well the cells are accepted after transplantation and is directly related to their degree of immunogenicity. In this study, hepatic differentiation of human umbilical cord mesenchymal stem cells (hUC‐MSCs) was induced in the traditional monolayer (2D) culture and newly established three‐dimensional (3D) aggregation culture with the porcine decellularized liver scaffold (DLS) system (3D‐DLS). We investigated the immunogenicity of these hepatocyte‐like cells in vitro. We found that monolayer hepatic differentiated hUC‐MSCs expressed higher levels of human leukocyte antigen‐DR (HLA‐DR) (P<.05) and lost the ability to inhibit lymphocyte proliferation (P<.05), in association with a lower level of prostaglandin E2 (PGE2) (P<.05) and a higher level of interferon‐γ (IFN‐γ) (P<.05) secretion, compared to undifferentiated hUC‐MSCs. The hepatocyte‐like cells differentiated in the 3D‐DLS system did not show an elevation of MHC‐II (P>.05), or cause obvious lymphocytes proliferation, and demonstrated more PGE2 (P<.05) and less IFN‐γ (P<.05) secretion. Hepatocyte‐like cells in the 3D‐DLS system presented a lower immunogenic phenotype than the 2D culture in vitro. Hepatocyte‐like cells in 3D‐DLS system also performed a higher immunosuppressive capacity than 2D culture.
Transient smartphone blindness: Relevance to misdiagnosis in neurologic practice
Sathiamoorthi, Saraniya , Wingerchuk, Dean M., Wingerchuk, Dean M.

Neurology | January 19, 2017 | Volume: 88 | Issue: 8 | Pages: 809-810

10.1212/wnl.0000000000003639 | PMID 28100724 Get It

Prospective Outcomes of a Pelvic Floor Rehabilitation Program Including Vaginal Electrogalvanic Stimulation for Urinary, Defecatory, and Pelvic Pain Symptoms
Schmitt, Jennifer, Singh, Ruchira, Weaver, Amy L. , Mara, Kristin C. , Harvey-Springer, Randina R., Fick, Felecia R., Occhino, John A. , Schmitt, Jennifer J, Mara, Kristin C

Female Pelvic Medicine & Reconstructive Surgery | January 18, 2017 | Volume: 23 | Issue: 2 | Pages: 108-113

10.1097/spv.0000000000000371 | PMID 28106652 Get It

Objectives This study evaluated our experience after implementing a pelvic floor rehabilitation program including behavioral modification, biofeedback, and vaginal electrogalvanic stimulation (EGS). Methods This prospective cohort study evaluated outcomes of patients with pelvic floor dysfunction (urinary or defecatory dysfunction, pelvic pain/dyspareunia) who underwent pelvic floor rehabilitation. Patients received 4 to 7 sessions (1 every 2 weeks) including biofeedback and concluded with 30 minutes of vaginal EGS. Surveys assessed subjective changes in symptoms; success was evaluated using a 10-point visual analog scale (VAS) at the final session (10 = most successful). Paired comparisons of responses at baseline and final treatment were evaluated. Results Ninety-four patients were followed up through therapy completion. Treatment indications included urinary (89.4%), defecatory (33.0%), and pelvic pain or dyspareunia (30.9%); 44.7% of patients had a combination of indications. Among women with urinary symptoms, the percentage reporting leakage decreased from 92.9% to 79.3% (P = 0.001), leakage at least daily decreased from 69.0% to 39.5% (P < 0.001), daily urgency with leakage decreased from 42.7% to 19.5% (P = 0.001), daily urgency without leakage decreased from 41.5% to 18.3% (P < 0.001), and median VAS rating (0 = not at all, 10 = a great deal) of daily life interference decreased from 5 to 1.5 (P < 0.001). The median success ratings were 8, 8, and 7 for treatment of urinary symptoms, pelvic pain/dyspareunia, and bowel symptoms, respectively. Conclusions An aggressive pelvic rehabilitation program including biofeedback with vaginal EGS had a high rate of self-reported subjective success and satisfaction and should be considered a nonsurgical treatment option in patients with pelvic floor dysfunction.
Acute Perioperative Pain Management in Total Joint Arthroplasty: Summary of Available Agents
Misra, Lopa

Topics in Pain Management | January 18, 2017 | Volume: 32 | Issue: 7 | Pages: 1-8

10.1097/01.tpm.0000512334.83805.11 Get It

DisseminatedMycobacterium interjectumInfection with Bacteremia, Hepatic and Pulmonary Involvement Associated with a Long-Term Catheter Infection
Sotello, David , Hata, D. Jane , Reza, Mohammed, Satyanarayana, Raj, Arunthari, Vichaya, Bosch, Wendelyn , Sotello Aviles, David A

Case Reports in Infectious Diseases | January 18, 2017 | Volume: 2017 | Issue: No issue available | Pages: 1-5

10.1155/2017/6958204 | PMID 28197350 Get It

We present a 49-year-old female with one year of intermittent fevers, chills, night sweats, and significant weight loss. Liver and lung biopsy showed evidence of a granulomatous process. Blood and liver biopsy cultures yielded growth of presumedMycobacterium interjectum, thought to be related to a disseminated long-term central venous catheter infection. She successfully received one year of combined antimicrobial therapy after catheter removal without recurrence of disease.M. interjectumhas been previously described as a cause of lymphadenitis in healthy children and associated with pulmonary disease in adults, although other localized infections have been reported. This is the first case described of a disseminatedM. interjectuminfection with bacteremia, hepatic and pulmonary involvement associated with a long-term catheter infection.
Outcomes of Rectovaginal Fistula Repair
Byrnes, Jenifer N., Schmitt, Jennifer, Faustich, Benjamin M., Mara, Kristin C. , Weaver, Amy L. , Chua, Heidi K, Occhino, John A. , Mara, Kristin C

Female Pelvic Medicine & Reconstructive Surgery | January 18, 2017 | Volume: 23 | Issue: 2 | Pages: 124-130

10.1097/spv.0000000000000373 | PMID 28106653 Get It

Objectives Rectovaginal fistulae (RVF) often represent surgical challenges, and treatment must be individualized. We describe outcomes after primary surgical repair stratified by fistula etiology and surgical approach. Methods This retrospective cohort study included women who underwent surgical management of RVF at a tertiary care center between July 1, 2001 and December 31, 2013. Cases were stratified according to the following etiology: cancer (RVF-C), inflammatory bowel disease or infectious (RVF-I), and other (RVF-O). Patients with prior surgical treatment of RVF were excluded. Surgical approaches included local (seton, plug), transvaginal or endorectal, abdominal, diversion alone, or definitive (completion proctocolectomy with permanent colostomy or pelvic exenteration). Recurrence-free survival was estimated using the Kaplan-Meier method, and comparisons between subgroups were evaluated based on fitting Cox proportional hazards models. Censoring occurred at last relevant clinical follow-up. Factors contributing to recurrence-free survival were evaluated including age, body mass index, smoking status, fistula etiology, ileostomy, and surgical approach. Results During the study period, 107 women underwent surgical repair of RVF. The most common fistula etiology was RVF-I (54.2%), followed by RVF-O (23.4%), and RVF-C (22.4%). Ninety-four women underwent fistula repair by the local (29.9%), transvaginal/endorectal (25.2%), abdominal approach (19.6%), or diversion alone (13.1%), whereas 13 underwent definitive surgery (12.2%). Recurrence-free survival was significantly different depending on surgical approach ( P < 0.001), but not etiology ( P = 0.71). Recurrence-free survival (95% confidence interval) at 1 year after surgery was 35.2% (21.8%–56.9%) for the local approach, 55.6% (37.0%–83.3%) for the transvaginal or endorectal approach, 95% (85.9%–100%) for the abdominal approach, and 33.3% (15%–74.2%) for those with diversion only. Conclusions Recurrence rates after RVF repair are high and did not differ by fistula etiology. Abdominal repair of RVF had significantly fewer recurrences.
Physician-Assisted Suicide and Euthanasia in the ICU: A Dialogue on Core Ethical Issues*
Goligher, Ewan C. , Ely, E. Wesley, Sulmasy, Daniel P., Bakker, Jan , Raphael, John, Volandes, Angelo E., Payne, Kate, Hosie, Annmarie , Churchill, Larry R., Downar, James , Ely, Eugene Wesley , Patel, Bhavesh , White, Douglas B. , Bakker, Jan

Critical Care Medicine | January 18, 2017 | Volume: 45 | Issue: 2 | Pages: 149-155

10.1097/ccm.0000000000001818 | PMID 28098622 Get It

Objective: Many patients are admitted to the ICU at or near the end of their lives. Consequently, the increasingly common debate regarding physician-assisted suicide and euthanasia holds implications for the practice of critical care medicine. The objective of this article is to explore core ethical issues related to physician-assisted suicide and euthanasia from the perspective of healthcare professionals and ethicists on both sides of the debate. Synthesis: We identified four issues highlighting the key areas of ethical tension central to evaluating physician-assisted suicide and euthanasia in medical practice: 1) the benefit or harm of death itself, 2) the relationship between physician-assisted suicide and euthanasia and withholding or withdrawing life support, 3) the morality of a physician deliberately causing death, and 4) the management of conscientious objection related to physician-assisted suicide and euthanasia in the critical care setting. We present areas of common ground and important unresolved differences. Conclusions: We reached differing positions on the first three core ethical questions and achieved unanimity on how critical care clinicians should manage conscientious objections related to physician-assisted suicide and euthanasia. The alternative positions presented in this article may serve to promote open and informed dialogue within the critical care community.
Identification of aurintricarboxylic acid as a selective inhibitor of the TWEAK-Fn14 signaling pathway in glioblastoma cells
Roos, Alison , Mathews, Ian T. , Inge, Landon J. , Tuncali, Serdar, Hartman, Lauren, Chow, Donald, Millard, Nghia , Yin, Holly, Kloss, Jean , Loftus, Joseph C. , Winkles, Jeffrey A. , Tran, Nhan L. , Dhruv, Harshil , Berens, Michael E. , Tran, Nhan L

Oncotarget | January 18, 2017 | Volume: 8 | Issue: 7 | Pages: 12234-12246

10.18632/oncotarget.14685 | PMID 28103571 Get It

Tolfenamic acid-induced alterations in genes and pathways in pancreatic cancer cells
Sankpal, Umesh T. , Goodison, Steve , Jones-Pauley, Michelle, Hurtado, Myrna , Zhang, Fan , Basha, Riyaz

Oncotarget | January 18, 2017 | Volume: 8 | Issue: 9 | Pages: 14593-14603

10.18632/oncotarget.14651 | PMID 28099934 Get It

Implementation of a Comprehensive Population Health Management Model
Matthews, Marc R. , Stroebel, Robert J. , Wallace, Mark R. , Bryan, Michael , Swanson, Jill A., Allen, Summer V. , Bunkers, Kari S., Bryan, Michael J, Matthews, Marc R

Population Health Management | January 18, 2017 | Volume: 20 | Issue: 5 | Pages: 337-339

10.1089/pop.2016.0130 | PMID 28099067 Get It